BerganKDV Wealth Management LLC Boosts Holdings in CVS Health Co. (NYSE:CVS)

BerganKDV Wealth Management LLC boosted its position in CVS Health Co. (NYSE:CVSGet Rating) by 6.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,887 shares of the pharmacy operator’s stock after acquiring an additional 1,577 shares during the quarter. BerganKDV Wealth Management LLC’s holdings in CVS Health were worth $2,721,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Vestor Capital LLC acquired a new stake in CVS Health in the first quarter valued at approximately $5,855,000. PYA Waltman Capital LLC acquired a new stake in CVS Health in the first quarter valued at approximately $68,000. Teacher Retirement System of Texas raised its holdings in CVS Health by 12.2% in the first quarter. Teacher Retirement System of Texas now owns 638,750 shares of the pharmacy operator’s stock valued at $64,648,000 after acquiring an additional 69,474 shares in the last quarter. Lincoln National Corp raised its holdings in CVS Health by 1.2% in the first quarter. Lincoln National Corp now owns 27,581 shares of the pharmacy operator’s stock valued at $2,791,000 after acquiring an additional 328 shares in the last quarter. Finally, WealthTrust Axiom LLC raised its holdings in CVS Health by 2.1% in the first quarter. WealthTrust Axiom LLC now owns 12,683 shares of the pharmacy operator’s stock valued at $1,283,000 after acquiring an additional 263 shares in the last quarter. Institutional investors and hedge funds own 78.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Loop Capital assumed coverage on shares of CVS Health in a report on Thursday, June 16th. They set a “buy” rating and a $120.00 price objective on the stock. Deutsche Bank Aktiengesellschaft raised their price objective on shares of CVS Health from $113.00 to $120.00 in a report on Thursday. UBS Group raised their price objective on shares of CVS Health from $118.00 to $127.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Sanford C. Bernstein cut shares of CVS Health from an “outperform” rating to a “market perform” rating and cut their price objective for the stock from $122.00 to $112.00 in a report on Thursday, May 26th. Four analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $116.90.

Insider Transactions at CVS Health

In other news, EVP Alan Lotvin sold 22,541 shares of the company’s stock in a transaction on Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the transaction, the executive vice president now directly owns 109,183 shares of the company’s stock, valued at approximately $11,355,032. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, EVP Thomas M. Moriarty sold 138,654 shares of the stock in a transaction dated Tuesday, June 28th. The shares were sold at an average price of $95.00, for a total value of $13,172,130.00. Following the sale, the executive vice president now directly owns 626,273 shares of the company’s stock, valued at approximately $59,495,935. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Alan Lotvin sold 22,541 shares of the stock in a transaction dated Thursday, August 4th. The shares were sold at an average price of $104.00, for a total transaction of $2,344,264.00. Following the completion of the sale, the executive vice president now directly owns 109,183 shares in the company, valued at $11,355,032. The disclosure for this sale can be found here. Corporate insiders own 0.69% of the company’s stock.

CVS Health Stock Performance

NYSE:CVS traded up $0.39 during midday trading on Friday, reaching $102.26. The stock had a trading volume of 4,285,449 shares, compared to its average volume of 5,079,330. The firm has a fifty day simple moving average of $94.36 and a two-hundred day simple moving average of $99.93. CVS Health Co. has a 12-month low of $80.15 and a 12-month high of $111.25. The company has a quick ratio of 0.62, a current ratio of 0.91 and a debt-to-equity ratio of 0.67. The stock has a market cap of $134.25 billion, a P/E ratio of 16.63, a P/E/G ratio of 1.55 and a beta of 0.75.

CVS Health (NYSE:CVSGet Rating) last posted its quarterly earnings data on Wednesday, August 3rd. The pharmacy operator reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $2.16 by $0.24. CVS Health had a net margin of 2.65% and a return on equity of 15.19%. The firm had revenue of $80.64 billion for the quarter, compared to analyst estimates of $76.38 billion. During the same period last year, the firm posted $2.42 EPS. CVS Health’s quarterly revenue was up 11.0% on a year-over-year basis. On average, equities analysts expect that CVS Health Co. will post 8.54 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 1st. Stockholders of record on Friday, July 22nd were paid a dividend of $0.55 per share. The ex-dividend date of this dividend was Thursday, July 21st. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.15%. CVS Health’s dividend payout ratio (DPR) is presently 35.77%.

CVS Health Company Profile

(Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Recommended Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSGet Rating).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.